Testimonial by David Riusech, Scientist, Noven Pharmaceuticals, Miami, FL, USA
“Hanson service representatives also helped demonstrate a few aspects of the calibration and PM procedure so that we can better understand the process. Very good professional job well done.”
Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery. We are a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches. Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the US DEA (Drug Enforcement Agency) for the production of controlled substances.